Edmund Dunn is Principal Accounting Officer of Monte Rosa Therapeutics, Inc.. Currently has a direct ownership of 25,794 shares of GLUE, which is worth approximately $154,506. The most recent transaction as insider was on Jan 02, 2025, when has been sold 11,850 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 25.8K
84.98% 3M change
n/a 12M change
Total Value Held $154,506

Edmund Dunn Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 02 2025
BUY
Grant, award, or other acquisition
-
11,850 Added 31.48%
25,794 Common Stock
Jul 05 2024
SELL
Open market or private sale
$6,166 $3.83 p/Share
1,610 Reduced 10.35%
13,944 Common Stock
Jun 03 2024
SELL
Open market or private sale
$4,876 $4.04 p/Share
1,207 Reduced 7.2%
15,554 Common Stock
ED

Edmund Dunn

Principal Accounting Officer
Boston, MA

Track Institutional and Insider Activities on GLUE

Follow Monte Rosa Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GLUE shares.

Notify only if
Any

Insider Trading

Get notified when an Monte Rosa Therapeutics, Inc. insider buys or sells GLUE shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to Monte Rosa Therapeutics, Inc.

Track Activities on GLUE